CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
0.5% carboxymethylcellulose (CMC) with purite and CMC alonedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00386646
NCT00386646Phase 4Completed
CompareCT.gov

A Comparative Study of 0.5% Carboxymethylcellulose With 0.005% Stabilized Oxychlorocomplex (PURITE™) Versus 0.5% Carboxymethylcellulose in the Treatment of Dry Eye: A Randomized Controlled Trial

Chulalongkorn University·interventional·Posted Oct 11, 2006·Updated Jun 3, 2015

In Brief

A Phase 4 clinical trial evaluating 0.5% carboxymethylcellulose (CMC) with purite and CMC alone for Dry Eye Syndromes. Completed, across 1 site.

Detailed Summary

To compare if 0.5% carboxymethylcellulose with 0.005% SOC (Stabilized oxychloro complex) have the same effectiveness and safety as 0.5% carboxymethylcellulose on dry eye patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye Syndromes
CountriesThailand
Collaborators--

Timeline

Phase 4CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 11, 2006
Enrollment StartFeb 1, 2004
Study CompletionOct 1, 2005
TodayJul 2, 2026
Posted 19.7 years ago

Interventions

0.5% carboxymethylcellulose (CMC) with purite and CMC alonedrug